Phase I clinical and pharmacokinetic trial of docetaxel and irinotecan administered on a weekly schedule

被引：0
|
作者：
Agustin A. Garcia
Mahesh Pujari
Susan Jeffers
Syma Iqbal
Heinz-Josef Lenz
Paul Beringer
Stan Louie
机构：
[1] University of Southern California,Norris Comprehensive Cancer Center, Keck School of Medicine
[2] University of Southern California,School of Pharmacy
[3] Women’s Cancer Research Institute,Cedars Sinai Medical Center
来源：
Cancer Chemotherapy and Pharmacology | 2005年 / 56卷
关键词：
Phase I; Clinical trial; Pharmacokinetics; Docetaxel; Irinotecan;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：75 / 82
页数：7
相关论文
共 50 条
  • [21] A phase I and pharmacokinetic trial of erlotinib in combination with weekly docetaxel in patients with taxane-naive malignancies
    Chiorean, E. Gabriela
    Porter, Jennifer M.
    Foster, Anne E.
    Al Omari, Amal S. H.
    Yoder, Christy A.
    Fife, Karen L.
    Strother, R. Matthew
    Murry, Daryl J.
    Yu, Menggang
    Jones, David R.
    Sweeney, ChristopherJ.
    CLINICAL CANCER RESEARCH, 2008, 14 (04) : 1131 - 1137
  • [22] Pharmacokinetic study of cystemustine, administered on a weekly schedule in cancer patients
    Cellarier, E
    Terret, C
    Labarre, P
    Ouabdesselam, R
    Curé, H
    Marchenay, C
    Maurizis, JC
    Madelmont, JC
    Chollet, P
    Armand, JP
    ANNALS OF ONCOLOGY, 2002, 13 (05) : 760 - 769
  • [23] Phase I and pharmacokinetic study of docetaxel and irinotecan in patients with advanced solid tumors
    Couteau, C
    Risse, ML
    Ducreux, M
    Lefresne-Soulas, F
    Riva, A
    Lebecq, A
    Ruffié, P
    Rougier, P
    Lokiec, F
    Bruno, R
    Armand, JP
    JOURNAL OF CLINICAL ONCOLOGY, 2000, 18 (20) : 3545 - 3552
  • [24] Phase I and pharmacokinetic trial of SJG-136 administered on a daily x 5 schedule.
    Puzanov, I
    Lee, W
    Berlin, JD
    Calcutt, MW
    Hachey, DL
    Vermeulen, W
    Low, J
    Rothenberg, ML
    CLINICAL CANCER RESEARCH, 2005, 11 (24) : 9061S - 9061S
  • [25] Phase I clinical trial of weekly combretastatin A4 phosphate: Clinical and pharmacokinetic results
    Rustin, GJS
    Galbraith, SM
    Anderson, H
    Stratford, M
    Folkes, LK
    Sena, L
    Gumbrell, L
    Price, PM
    JOURNAL OF CLINICAL ONCOLOGY, 2003, 21 (15) : 2815 - 2822
  • [26] A Phase I trial of weekly docetaxel and topotecan for solid tumors
    Lim, Wan Teck
    Baggstrom, Maria Q.
    Read, William
    Fracasso, Paula M.
    Govindan, Ramaswamy
    ACTA ONCOLOGICA, 2008, 47 (02) : 311 - 315
  • [27] Phase I trial of a new nitrosurea ina weekly schedule
    Terret, C
    Goncalves, E
    DaCosta, L
    Urosevic, V
    Chollet, P
    Madelmont, J
    Armand, JP
    EUROPEAN JOURNAL OF CANCER, 1995, 31A : 960 - 960
  • [28] A PHASE-I TRIAL OF MARCELLOMYCIN WITH A WEEKLY DOSE SCHEDULE
    JOSS, RA
    KAPLAN, S
    GOLDHIRSCH, A
    VARINI, M
    BRUNNER, KW
    CAVALLI, F
    EUROPEAN JOURNAL OF CANCER & CLINICAL ONCOLOGY, 1983, 19 (04): : 455 - 459
  • [29] PHASE-I STUDY OF ORAL MENOGARIL ADMINISTERED ON A ONCE WEEKLY SCHEDULE
    STEWART, DJ
    VERMA, S
    MAROUN, JA
    ROBILLARD, L
    EARHART, RH
    INVESTIGATIONAL NEW DRUGS, 1990, 8 (01) : 43 - 52
  • [30] Phase I and pharmacokinetic study of irinotecan and docetaxel in patients with advanced solid tumors: Preliminary evidence of clinical activity
    Adjei, AA
    Klein, CE
    Kastrissios, H
    Goldberg, RM
    Alberts, SR
    Pitot, HC
    Sloan, JA
    Reid, JM
    Hanson, LJ
    Atherton, P
    Rubin, J
    Erlichman, C
    JOURNAL OF CLINICAL ONCOLOGY, 2000, 18 (05) : 1116 - 1123
12345